1227089-91-9

Basic information

• Product Name: N-(3-(6-(1H-indazol-4-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)acetamide
• Synonyms: N-(3-(6-(1H-indazol-4-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)acetamide
• CAS NO: 1227089-91-9
• Molecular Weight: 382.425
• Mol File: 1227089-91-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-(6-(1H-indazol-4-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-(6-(1H-indazol-4-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)acetamide(1227089-91-9)
• EPA Substance Registry System: N-(3-(6-(1H-indazol-4-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)acetamide(1227089-91-9)

Safety Data

• Hazardous Substances Data: 1227089-91-9(Hazardous Substances Data)

Upstream product

• 480424-93-9 N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide 
• 1227089-75-9 4-chloro-6-(1H-indazol-4-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridine 

Relevant articles and documents

PYRAZOLOPYRIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

Compounds of Formula (I), and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer or inflammation mediated by lipid kinases. Methods of using compounds of Formula (I) for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.